Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cowen Healthcare Investments was a healthcare-focused investment manager and venture/growth equity investor based in New York that invested in biopharmaceutical, healthcare, diagnostics, and related life sciences companies. It was founded in 2012 and operated as part of Cowen Investment Management, building a portfolio across private and public healthcare opportunities with a particular emphasis on mid-to-late-stage companies. In October 2023, Blue Owl Capital announced an agreement to acquire the funds managed by Cowen Healthcare Investments, and the team subsequently became part of Blue Owl. Following the transaction, the strategy was rebranded as Blue Owl Healthcare Opportunities. This is therefore a healthcare investor rather than a drug-developing biotech or pharma operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cowen Healthcare Investors.